Treatment of White Coat HYpertension in the Very Elderly Trial (HYVET 2) - Feasibility of a Randomized Controlled Trial (Study Protocol)
- 10.2991/artres.k.191106.001How to use a DOI?
- White coat hypertension; treatment; feasibility study; very elderly
The results of HYpertension in the Very Elderly Trial (HYVET) were crucial in providing evidence of benefit of the treatment of hypertension in those 80 years or older. Following a subsequent sub study analysis of the HYVET data there is a suggestion that 50% of patients in the main study had White Coat Hypertension (WCH), defined as clinic BP readings >140/90 mmHg and ambulatory BP readings <135/85 mmHg. Currently, definitive evidence in support of treatment for such individuals is not available. HYVET 2 has been designed in order to assess the feasibility of conducting a randomized controlled trial which might determine whether the treatment of WCH in the very elderly is clinically beneficial. One hundred participants aged ≥75 years diagnosed with WCH will be recruited from General Practices (GPs) in UK. Randomization will be 1:1 to a treatment arm (indapamide and perindopril) and control arm (no treatment) and follow up will be for 52 weeks. HYVET 2 will report on feasibility outcomes including participant recruitment, adherence and withdrawal rates, willingness of GPs to recruit and randomize patients and the frequency of a composite of cardiovascular events. Simple descriptive statistics will be presented.
- © 2019 Association for Research into Arterial Structure and Physiology. Publishing services by Atlantis Press International B.V.
- Open Access
- This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - JOUR AU - Michael Okorie AU - Khalid Ali AU - Stephen Bremner AU - Nigel Beckett AU - Stephen Jackson AU - Richard Quirk AU - Colin McAlister AU - Nicky Perry AU - John Potter AU - Christopher Bulpitt AU - Chakravarthi Rajkumar PY - 2019 DA - 2019/11/18 TI - Treatment of White Coat HYpertension in the Very Elderly Trial (HYVET 2) - Feasibility of a Randomized Controlled Trial (Study Protocol) JO - Artery Research SP - 19 EP - 25 VL - 25 IS - 1-2 SN - 1876-4401 UR - https://doi.org/10.2991/artres.k.191106.001 DO - 10.2991/artres.k.191106.001 ID - Okorie2019 ER -